Mirtazapine-D3 manufacturers
- Mirtazapine-D3
-
-
2026-04-22
- CAS:1216678-68-0
- Purity:
- Supply Ability: 10g
|
| | Mirtazapine-D3 Basic information |
| Product Name: | Mirtazapine-D3 | | Synonyms: | Mirtazapine-D3;1,2,3,4,10,14b-Hexahydro-2-(methyl-d3)-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine;Org-3770-d3;Remeron-d3;Zispin-d3;1,2,3,4,10,14b-Hexahydro-2-(methyl-d3)-pyrazino[2,1-α]pyrido[2,3-c][2]benzazepine;MIRTAZAPINE (D3, 98%) 100 UG/ML IN METHANOL;Mirtazapine-d3 (N-methyl-d3) | | CAS: | 1216678-68-0 | | MF: | C17H19N3 | | MW: | 265.35286 | | EINECS: | | | Product Categories: | Intermediates & Fine Chemicals;Isotope Labeled Compounds;Pharmaceuticals;Heterocycles;Isotope Labelled Compounds | | Mol File: | 1216678-68-0.mol |  |
| | Mirtazapine-D3 Chemical Properties |
| Melting point | 105-107°C | | storage temp. | -20°C Freezer | | solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) | | form | Solid | | color | White to Light Beige |
| | Mirtazapine-D3 Usage And Synthesis |
| Chemical Properties | Off-White to Pale Yellow Solid | | Uses | An a 2-Adrenergic blocker. An analogue of Mianserin. Antidepressant | | Uses | An α2-Adrenergic blocker; analogue of Mianserin. Antidepressant. | | in vivo | Mirtazapine (intraperitoneal injection; 10-50 mg/Kg; 14 days) treatment normalizes heart rate, breath rate, anxiety levels and eliminates the hopping behavior observed in MeCP2-null mice, leading to improved phenotypic score[2]. | Animal Model: | MeCP2 null mice[2] | | Dosage: | 10-50 mg/Kg | | Administration: | Intraperitoneal injection; 10-50 mg/Kg; 14 days | | Result: | Restored the thickness of MeCP2-null mice somatosensory cortex, especially of layers II-III and VI. |
| | IC 50 | 5-HT2 Receptor; 5-HT3 Receptor |
| | Mirtazapine-D3 Preparation Products And Raw materials |
|